Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro
Open Access
- 1 April 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 102 (4) , 909-915
- https://doi.org/10.1111/j.1476-5381.1991.tb12275.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- 9-Amino-1,2,3,4-tetrahydroacridin-1-ols. Synthesis and evaluation as potential Alzheimer's disease therapeuticsJournal of Medicinal Chemistry, 1989
- Effects of THA on ionic currents in myelinated axons of Xenopus laevisEuropean Journal of Pharmacology, 1989
- 9-Amino-1,2,3,4-tetrahydroacridine (THA) blocks agonist-induced potassium conductance in rat hippocampal neuronesEuropean Journal of Pharmacology, 1989
- Single Dose Safety, Tolerance, and Pharmacokinetics of HP 029 in Healthy Young Men: A Potential Alzheimer AgentThe Journal of Clinical Pharmacology, 1989
- (.+-.)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicityJournal of Medicinal Chemistry, 1988
- HEPATOTOXICITY OF TETRAHYDROACRIDINEThe Lancet, 1988
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- Alzheimer's Drug Trial Put on HoldScience, 1987
- Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neuronsEuropean Journal of Pharmacology, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986